The interconnection between the endoplasmic reticulum (ER) and mitochondria to transfer Ca2+ into the mitochondrial matrix constitutes a major part of intracellular Ca2+ signaling. By increasing mitochondrial Ca2+ ([Ca2+]m) uptake, ER-mitochondrial crosstalk enhances energy production through accelerating mitochondrial respiration, thereby supporting cellular function and survival.
ER-mitochondrial associations are established by multiprotein complexes formed, for instance, by ER-bound inositol-1,4,5-trisphosphate receptor (IP3R), mitochondria-resident voltage-dependent anion channel 1 (VDAC1) and the heat shock protein glucose-regulated protein 75 (GRP75)1. While IP3R and VDAC1 are Ca2+-permeable ion channels driving Ca2+ flux, GRP75 is essential to maintain the physical contact between the organelles, thereby facilitating the propagation of the Ca2+ signal into the mitochondria2. Reduced GRP75 expression in tumor cells derived from bone, breast or colon has been linked to an increased susceptibility to cell death, and small molecule GRP75-inhibitory drugs are exploited as a potential therapeutic intervention3. However, the relevance of GRP75 for ER-mitochondrial crosstalk in neurons or brain-derived tumor cells is largely unknown.
Under physiological conditions, GRP75 inhibition seemed to activate mitochondrial stress responses such as the mitochondrial unfolded protein response or autophagy in human neuroblastoma SH-SY5Y cells4. In contrast, under pathological conditions, GRP75 expression exerted different effects. For instance, in SH-SY5Y cells increased GRP75 expression prevented mitochondrial dysfunction and cell death following proteolytic stress induced by overexpression of mitochondrial ornithine transcarbamylase5. In contrast, in human dopaminergic neurons, GRP75 overexpression potentiated the cytotoxic effects of the mitochondrial complex I inhibitor rotenone6.
Our recent study published in Cell Death & Discovery7 provided further insights into the role of GRP75 on mitochondrial dysfunction and cell death in a neuronal model of oxidative stress. Using immortalized hippocampal HT22 cells, we investigated the consequences of GRP75 expression on cell survival in a model of glutamate-induced oxytosis. In this study, inhibition and/or gene silencing of GRP75 via siRNA or CRISPR/Cas9-knockout fully prevented the oxidative cell death. In particular, GRP75 depletion exerted protection by preserving the mitochondrial network, preventing mitochondrial membrane depolarization and restoring the mitochondrial redox balance. Furthermore, GRP75 depletion restored Ca2+ homeostasis by preventing [Ca2+]m overload and late-stage cytosolic Ca2+ dysregulation mediated by Ca2+ release-activated calcium channel protein 1 (ORAI1). In turn, elevating GRP75 expression increased the sensitivity of neural HT22 cells towards the glutamate challenge. Notably, neither pharmacological inhibition alone nor genetic downregulation of GRP75 had any effect on cell survival or mitochondrial function in control conditions. GRP75 gene silencing neither impaired cell proliferation, nor altered the mitochondrial network, mitochondrial ROS, or the mitochondrial membrane potential. We therefore suggest that the GRP75-dependent ER-mitochondrial coupling is a major determinant of cell fate in conditions of oxidative stress, without affecting mitochondrial function and cell viability in physiological conditions.
GRP75 is a chaperone interacting with other proteins to regulate mitochondrial protein import, and to activate pro-survival signaling pathways through MAPK activation or pro-apoptotic p53-dependent signaling cascades8, 9. In hepatocellular carcinoma cells, GRP75 inhibition substantially enhanced cell death which was linked to an increase in the nucleo-cytoplasmic shuttling of the tumor suppressor p53, thereby driving apoptosis10. However, p53 function was dispensable for glutamate toxicity in neural HT22 cells11, supporting the concept that the primary function of GRP75 was determining ER-mitochondrial contact formation in these cells.
GRP75 is an adapter protein that bridges the ER to mitochondrial membranes through facilitating the interaction between IP3R and VDAC1. Using in situ proximity ligation assays, we confirmed a pivotal role for GRP75 in physically bridging ER and mitochondrial since pharmacological inhibition significantly reduced the number of ER-mitochondrial interaction sites. Exposing HT22 cells to glutamate induced oxidative cell death which is associated with mitochondrial dysfunction12 but without affecting ER function. In these cells, GRP75 knockdown fully blocked cell death by reducing ER-mitochondrial coupling, suggesting that Ca2+ signaling along the ER-mitochondrial interface contributed to glutamate toxicity. In some cell types, ER dysfunction can result in impaired mitochondrial function13 through increased ER-mitochondrial Ca2+ transfer and alterations in mitochondrial respiration. However, ER stress induced in HT22 cells led to caspase-dependent cell death that was independent of mitochondrial damage14. In line with these earlier findings, GRP75 inhibition/depletion was not able to rescue ER stress-induced cell death in our study. In addition, mitochondrial damage elicited by the mitochondrial complex I inhibitor rotenone was also not blocked by GRP75 inhibition/downregulation. Thus, the GRP75-mediated regulation of ER-mitochondrial connectivity determines neurotoxicity in paradigms of oxidative stress upstream of mitochondrial damage; yet detrimental ER dysfunction and associated death signaling is apparently independent of GRP75-mediated connectivity to mitochondria.
[Ca2+]m homeostasis and mitochondrial energy production are regulated by the transfer of small Ca2+ microdomains through the ER-mitochondrial interface. Yet large Ca2+ microdomains shuttled into mitochondria exceed the capacity of mitochondria to buffer changes in Ca2+ concentrations, leading to [Ca2+]m overload and to an impairment of mitochondrial function15. We show that decreasing GRP75 expression in physiological conditions did not affect mitochondrial function or cell survival while the overexpression of GRP75 increased ER-mitochondrial coupling and accelerated the susceptibility of HT22 cells to oxidative stress. These findings suggest that in neural HT22 cells, ER-mitochondrial coupling mediated by GRP75 is particularly relevant during cellular stress. Furthermore, our results indicate that basal ER-mitochondrial coupling may be low in physiological conditions, and therefore, modulating the coupling strength by GRP75 downregulating is without consequences for cellular function and survival. Thus, we propose different scenarios for GRP75 function depending largely on the cell type and signaling context (Fig. 1). In the first scenario representing published findings in brain-derived tumor cells, ER and mitochondria are tightly associated which is essential for mitochondrial integrity and function. Therefore, GRP75 knockdown was accompanied by disruption of ER-mitochondrial connectivity, mitochondrial dysfunction and cell death. In these cell types, oxidative stress disrupted GRP75-dependent ER-mitochondrial connectivity, thus restoring GRP75 expression then prevented mitochondrial dysfunction and cell death. In the second, alternative scenario representing neuronal cells, ER-mitochondrial connections are dispensable and, therefore, the knockdown of GRP75 has no effect on mitochondrial function in physiological conditions, as we have demonstrated in neural HT22 cells in our study. Exposing these cells to oxidative stress, however, may potentiate Ca2+ transfer and associated signaling along the ER-mitochondrial axis, likely attributed to increased GRP75 expression, thereby amplifying the cytotoxic effects. Hence, as reported in our current study, decreasing ER-mitochondrial coupling through depletion of GRP75 renders resistance against oxidative cell death in neuronal cells.
Acknowledgements
This work was supported by a grant from the German Research Foundation (DO 1525/3-1). AMD is the recipient of a Rosalind Franklin Fellowship co-funded by European Union and University of Groningen.
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Birgit Honrath, Phone: +31 50 363 6372, Email: b.honrath@rug.nl.
Amalia M Dolga, Email: a.m.dolga@rug.nl.
References
- 1.Lebiedzinska, et al. Int J. Biochem Cell Biol. 2009;41:1805–1816. doi: 10.1016/j.biocel.2009.02.017. [DOI] [PubMed] [Google Scholar]
- 2.Phillips, et al. Nat. Rev. Mol. Cell Biol. 2015;17:1–14. [Google Scholar]
- 3.Deocaris, et al. Cancer Lett. 2007;252:259–269. doi: 10.1016/j.canlet.2006.12.038. [DOI] [PubMed] [Google Scholar]
- 4.Burbulla, et al. Cell Death Dis. 2014;5:e1180. doi: 10.1038/cddis.2014.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Burbulla, et al. Hum. Mol. Genet. 2010;19:4437–4452. doi: 10.1093/hmg/ddq370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jin, et al. Mol. Cell Proteom. 2006;5:1193–1204. doi: 10.1074/mcp.M500382-MCP200. [DOI] [PubMed] [Google Scholar]
- 7.Honrath, et al. Cell Death Discov. 2017;3:17076. doi: 10.1038/cddiscovery.2017.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lu, et al. Cell Death Differ. 2011;18:1046–1056. doi: 10.1038/cdd.2010.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Guo, et al. Mol. Med Rep. 2012;6:1423–1427. doi: 10.3892/mmr.2012.1070. [DOI] [PubMed] [Google Scholar]
- 10.Guo, et al. PLoS One. 2014;9:e85766. doi: 10.1371/journal.pone.0085766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Neitemeier, et al. Apoptosis. 2014;19:1665–1677. doi: 10.1007/s10495-014-1048-2. [DOI] [PubMed] [Google Scholar]
- 12.Honrath, et al. Cell Death Differ. 2017;24:1–13. doi: 10.1038/cdd.2017.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bravo, et al. J. Cell Sci. 2011;124:2143–2152. doi: 10.1242/jcs.080762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Richter, et al. Cell Death Differ. 2015;23:1–14. [Google Scholar]
- 15.Egnatchik, et al. Mol. Metab. 2014;3:544–553. doi: 10.1016/j.molmet.2014.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]